RU97102277A - HEMOSORPTION METHOD - Google Patents

HEMOSORPTION METHOD

Info

Publication number
RU97102277A
RU97102277A RU97102277/14A RU97102277A RU97102277A RU 97102277 A RU97102277 A RU 97102277A RU 97102277/14 A RU97102277/14 A RU 97102277/14A RU 97102277 A RU97102277 A RU 97102277A RU 97102277 A RU97102277 A RU 97102277A
Authority
RU
Russia
Prior art keywords
hemosorption
blood
antioxidant
hemosorbent
involving
Prior art date
Application number
RU97102277/14A
Other languages
Russian (ru)
Other versions
RU2137508C1 (en
Inventor
С.И. Кузнецов
О.Ю. Янковский
О.В. Рынцын
Н.В. Буркова
Ю.А. Эйсмонт
П.А. Канаев
А.И. Тюкавин
Original Assignee
Санкт-Петербургская медицинская академия последипломного образования
Filing date
Publication date
Application filed by Санкт-Петербургская медицинская академия последипломного образования filed Critical Санкт-Петербургская медицинская академия последипломного образования
Priority to RU97102277A priority Critical patent/RU2137508C1/en
Priority claimed from RU97102277A external-priority patent/RU2137508C1/en
Publication of RU97102277A publication Critical patent/RU97102277A/en
Application granted granted Critical
Publication of RU2137508C1 publication Critical patent/RU2137508C1/en

Links

Claims (2)

1. Способ проведения гемосборции, предусматривающий прохождение крови через гемосорбент, отличающийся тем, что процесс гемосорбции проводят на фоне введения в кровь антиоксидантных препаратов.1. The method of hemosorption, involving the passage of blood through the hemosorbent, characterized in that the hemosorption process is carried out against the background of the introduction of antioxidant drugs into the blood. 2. Способ по п. 1, отличающийся тем, что в качестве антиоксидантного препарата вводят супероксиддисмунтазу в дозе 50-500 мкг/кг. 2. The method according to p. 1, characterized in that superoxide dismutase is administered at a dose of 50-500 μg / kg as an antioxidant preparation.
RU97102277A 1997-02-14 1997-02-14 Method of hemosorption carrying out RU2137508C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU97102277A RU2137508C1 (en) 1997-02-14 1997-02-14 Method of hemosorption carrying out

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU97102277A RU2137508C1 (en) 1997-02-14 1997-02-14 Method of hemosorption carrying out

Publications (2)

Publication Number Publication Date
RU97102277A true RU97102277A (en) 1999-02-27
RU2137508C1 RU2137508C1 (en) 1999-09-20

Family

ID=20189917

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97102277A RU2137508C1 (en) 1997-02-14 1997-02-14 Method of hemosorption carrying out

Country Status (1)

Country Link
RU (1) RU2137508C1 (en)

Similar Documents

Publication Publication Date Title
HUT61031A (en) Process for producing chemically modified, stable haemoglobin substituting for non-immunogehic red blood cell, and pharmaceutical compositions comprising same as active ingredient
ZA894728B (en) A new pharmaceutical formulation as well as a process for its preparation
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
ATE67677T1 (en) MEDICATIONS FOR ORAL ADMINISTRATION CONTAINING 10 TO 240 MG OF DIHYDROPYRIDINE IN A SINGLE DOSE.
IL147220A0 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
EG19642A (en) A process for the preparation of oral composition for the treatment of inflammatory bowel diseases
CA2214503A1 (en) Method for treating tumors
CA2189916A1 (en) A new regime for paclitaxel in kaposi's sarcoma patients
CA2336945A1 (en) Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
CA2030962A1 (en) Improvements relating to the administration of pharmaceutical agents
WO2000008007A3 (en) Cyclopentabenzofuran derivatives and their use
CA2150183A1 (en) Pharmaceutical composition for the treatment of hemorrhoidal diseases
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
EP1304108A3 (en) Anti-arrhythmic composition and methods of treatment
WO1997048382A3 (en) Multiple-unit type prolonged action drug preparation
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
CA2091134A1 (en) Therapeutic agent for threatened abortion
RU97102277A (en) HEMOSORPTION METHOD
JP2002535286A5 (en)
EP0370300A3 (en) Cyclopropyl-substituted azolyl methyl carbinoles, process for their preparation and their use as therapeutic agents
GR3034886T3 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them
GR3035710T3 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and the use of pharmaceutical preparations based on these compounds as well as medicaments containing them
RU93047049A (en) NEW PHOSPHOLIPIDES DERIVATIVES
PL319160A1 (en) Codeine containing preparation